Calidad de vida en pacientes con tratamiento anticoagulante oral

Criado‐Álvarez, Juan José; González, Jaime González; Garcia, Sabrina Nunes; Barrientos, Carmen Romo

doi:10.1016/j.medcli.2014.02.011

Cited by 3 publications

(3 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our results are consistent with those reported by Gobbens and Remmen [32] in a previous study. In addition, our findings are consistent with those obtained by Criado-Álvarez et al [33] in a similar study in the Spanish population treated with OA. Although no statistical differences between men and women were found, women's social QoL was comparatively lower than men's.…”

Section: Discussionsupporting

confidence: 93%

Sense of Coherence and Quality of Life in Patients Treated with Antivitamin K Oral Anticoagulants: A Cross-Sectional Study

Anguas-Gracia

Subirón-Valera

Rodríguez-Roca

et al. 2021

IJERPH

View full text Add to dashboard Cite

The aim of this study was to analyze the correlation between the participants’ self-reported quality of life and their sense of coherence in a sample (n = 85) of patients on treatment with oral antivitamin K anticoagulants. A cross-sectional design was used. The measurement instruments included a questionnaire on sociodemographic variables, the Spanish version of the Abbreviated World Health Organization Quality of Life questionnaire (WHOQOL-BREF), an oral-anticoagulant-treatment-specific quality-of-life questionnaire, and the sense-of-coherence (SOC) scale. We analyzed the correlations between the participants’ characteristics and the results from the quality-of-life and SOC scales. Age, level of education, employment status, living arrangement, and treatment length were the determinants of the quality of life in people treated with oral anticoagulants. We found a significant association between the four domains of the WHOQOL-BREF questionnaire and general treatment satisfaction (p < 0.01); no significant correlations were found between the SOC subscales and the oral-anticoagulant-treatment-specific quality of life in our sample. Women had a worse level of self-management than men. Nursing interventions should be tailored to the needs of the populations on treatment with oral anticoagulants in order to facilitate a higher level of self-management.

show abstract

Section: Discussionsupporting

confidence: 93%

Sense of Coherence and Quality of Life in Patients Treated with Antivitamin K Oral Anticoagulants: A Cross-Sectional Study

Anguas-Gracia

Subirón-Valera

Rodríguez-Roca

et al. 2021

IJERPH

View full text Add to dashboard Cite

show abstract

“…The prescription rate of oral anticoagulants in our study was relatively high compared the published data of other authors—80.3% of the physicians dealing with AF (mostly cardiologists) stated their patients had been treated with an OAC (VKA or DOAC) for prevention of embolic events [1,2,3,4]. Atrial fibrillation was the most common indication for prescription of OAC [7,8,9,10,11,12,13,14]. This could be explained by the high prevalence of this arrhythmia in the general population (25% long-life risk for at least one episode of AF in people aged >40 years) and probably by the significantly improved awareness of the cardiologists and other health specialists for the last two decades about the cardio-embolic risk of AF [11,12,15,16,17].…”

Section: Discussionmentioning

confidence: 56%

“…Patients want to participate actively in the decision-making about the proposed procedures or treatments and to know all their alternatives [4,5]. The environment in which patients consume medical and health information has changed dramatically during the past decades worldwide [9,10]. The rapid diffusion of Internet technologies within the public sphere has placed an unprecedented amount of health information within reach of general consumers [6].…”

Section: Discussionmentioning

confidence: 99%

Physicians’ Perceptions of Their Patients’ Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria

et al. 2019

View full text Add to dashboard Cite

Background and Objectives: Oral anticoagulation (OAC) is widely used in daily clinical practice worldwide for various indications. We aimed to explore the perception of Bulgarian clinicians about their patients’ attitude and knowledge of long-term OAC, prescribed for atrial fibrillation (AF) and/or known deep venous thrombosis (DVT)/pulmonary embolism (PE). Materials and Methods: We performed a cross-sectional study that involved 226 specialists: 187 (82.7%) cardiologists, 23 (10.2%) neurologists, and 16 (7.1%) vascular surgeons. They filled in a questionnaire, specially designed for our study, answering various questions regarding OAC treatment in their daily clinical practice. Results: The mean prescription rate of OACs in AF patients was 80.3% and in DVT/PE—88.6%. One hundred and eighty-seven (82.7%) of the participants stated they see their patients on OAC at least once per month. According to more than one-third of the inquired clinicians, the patients did not understand well enough the provided information concerning net clinical benefit of OAC treatment. About 68% of the clinicians declared that their patients would prefer a “mutual” approach, discussing with the physician the OAC options and taking together the final decision, whereas according to 43 (19.0%), the patients preferred the physician to take a decision for them. Patients’ OAC treatment had been interrupted at least once within the last year due to a physician’s decision by 178 (78.8%) of the participants and the most common reason was elective surgery. The most influential factors for a patient’s choice of OAC were the need of a specific diet to be kept, intake frequency, and possible adverse reactions. Conclusions: Our results suggest that a clinician’s continuous medical education, shared decision-making, and appropriate local strategies for improved awareness of AF/DVT/PE patients are key factors for improvement of OAC management.

show abstract

Health-Related Quality of Life in Patients Under Treatment With Apixaban in Latin America

Villalba

Cortés

Garmendia

et al. 2022

Current Problems in Cardiology

View full text Add to dashboard Cite

Calidad de vida en pacientes con tratamiento anticoagulante oral

Cited by 3 publications

References 8 publications

Sense of Coherence and Quality of Life in Patients Treated with Antivitamin K Oral Anticoagulants: A Cross-Sectional Study

Sense of Coherence and Quality of Life in Patients Treated with Antivitamin K Oral Anticoagulants: A Cross-Sectional Study

Physicians’ Perceptions of Their Patients’ Attitude and Knowledge of Long-Term Oral Anticoagulant Therapy in Bulgaria

Health-Related Quality of Life in Patients Under Treatment With Apixaban in Latin America

Contact Info

Product

Resources

About